Wound Care Practice Revenue Model: What You Can Actually Earn in 2026

Wound Care Practice Revenue Model: What You Can Actually Earn

Most people researching wound care practice revenue want a single number. The honest answer: it depends on your visit volume, service mix, payer composition, and whether your billing operation actually collects what you earn.

The numbers are knowable, though. Wound care reimbursement follows published Medicare fee schedules, and the procedural mix in a typical mobile practice falls within a predictable range. This post breaks down per-visit revenue by service type, projects monthly revenue at realistic volumes, and walks through the cost structure that determines how much you keep.

If you're building a mobile wound care business, these are the economics underneath the business plan.

Revenue Per Visit: The Real Numbers

Wound care visit revenue varies dramatically based on what you do during the visit. A straightforward E/M encounter pays a fraction of a visit that includes debridement or skin substitute application. Understanding these tiers is the foundation of revenue modeling.

All figures below reference 2026 Medicare Physician Fee Schedule rates for non-facility (place of service 12 — home) settings. Commercial and Medicare Advantage rates vary by contract but generally follow Medicare as a baseline.

E/M Only Visit: ~$90-100

The simplest wound care visit is an evaluation and management encounter — assessment, wound measurement, dressing change, care plan update.

CPT 99213 (established patient, low complexity): ~$90
CPT 99214 (established patient, moderate complexity): ~$130

Most routine follow-ups without procedures fall here. A practice billing only E/M codes will struggle to reach profitability — the per-visit revenue doesn't cover the overhead of travel, supplies, and documentation time. E/M-only visits are the floor of your revenue model, not the target.

E/M + Debridement: ~$120-180

Adding debridement is where mobile wound care revenue starts to be economically viable. Debridement is clinically indicated for most chronic wounds at some point in the treatment cycle and is separately billable alongside E/M.

CPT 97597 (selective debridement, first 20 sq cm): ~$55-65 added to E/M
CPT 11042 (excisional debridement, subcutaneous tissue): ~$90-110 added to E/M

Combined visit revenue for E/M + debridement typically lands between $120 and $180 depending on the E/M level and debridement depth.

Key documentation requirement: modifier -25 on the E/M code, indicating a separately identifiable E/M service on the same day as the procedure. Without the -25 modifier, the E/M claim will be denied. This is one of the most common wound care billing denial triggers for new practices.

E/M + Skin Substitute Application: ~$800-1,500+

Skin substitute application is the highest-revenue visit type in mobile wound care. A single graft visit can generate more revenue than a week of E/M-only visits.

CPT 15271 (application of skin substitute graft to trunk, arms, legs, first 25 sq cm): ~$200-250
CPT 15275 (application to feet, first 25 sq cm): ~$200-250
Q-code for the specific skin substitute product: varies by product, typically $300-1,200+ per application

Combined revenue for an E/M + skin substitute application visit ranges from roughly $800 to over $1,500, depending on the product used and wound size.

The economics are compelling but come with significant caveats:

Supply cost is high. Skin substitute products can cost $200-800+ per unit at acquisition. Your margin depends on the spread between acquisition cost and reimbursement.
Denial risk is elevated. Skin substitutes face the highest prior authorization burden and the strictest Medicare documentation requirements. LCD compliance is non-negotiable.
Product changes affect reimbursement. CMS reclassified several skin substitute products in 2025-2026, and reimbursement rates have shifted. You need to track which products are in which CMS category and how that affects your Q-code reimbursement.

For a deeper breakdown of graft billing, see the skin substitute billing guide.

E/M + NPWT: ~$140-200

Negative pressure wound therapy (NPWT) adds moderate revenue when the provider applies or adjusts the device during the visit.

CPT 97607 (NPWT, surface area less than or equal to 50 sq cm): ~$50-70 added to E/M

NPWT visits generate less per-encounter revenue than debridement or graft application, but they create recurring visit volume. Patients on NPWT typically require regular dressing changes and device checks, generating consistent weekly visits over multi-week treatment courses.

The revenue impact of NPWT is more about visit frequency than per-visit margin.

Monthly Revenue Projections

Per-visit revenue matters, but monthly revenue is what pays the bills. Here's what realistic volume ramps look like.

Solo Provider — Year 1

A solo wound care provider doing mobile visits will typically manage 4-6 patient visits per day, factoring in travel time, documentation, and the operational overhead of running a one-person practice.

Conservative estimate (4 visits/day):

4 visits/day x 20 working days = 80 visits/month
At $120 average (mostly E/M + debridement): $9,600/month
At $150 average (adding some graft visits): $12,000/month

Stretch estimate (6 visits/day):

6 visits/day x 20 working days = 120 visits/month
At $130 average: $15,600/month
At $160 average: $19,200/month

The variable that swings this most is service mix. A provider doing one skin substitute application per day alongside three E/M + debridement visits will average closer to $250 per visit and generate $20,000+/month on just four visits a day.

Growing Practice — Year 2

Adding a second provider doesn't double revenue because it adds coordination overhead, but it does create the leverage point where the practice becomes meaningfully profitable.

Two providers, 6 visits/day each:

12 visits/day x 20 working days = 240 visits/month
At $130 average: $31,200/month (~$374,000 annualized)
At $160 average: $38,400/month (~$461,000 annualized)

At this scale, the practice can support dedicated administrative and billing staff, which improves collection rates and reduces the founders' non-clinical workload. It's also the inflection point where referral network investment starts compounding — facilities prefer working with practices that have backup capacity and won't miss visits when one clinician is unavailable.

Payer Mix Impact on Revenue

Two practices with identical visit volumes and service mixes will generate different revenue if their payer compositions differ. Payer mix is the often-overlooked variable in wound care revenue modeling.

Medicare Fee-for-Service is the baseline. Published rates, predictable payment timelines (14-21 days), established LCD criteria. The most transparent and reliable revenue source.

Medicare Advantage pays 5-15% below Medicare FFS on average and adds prior authorization overhead per claim. Still profitable, but thinner margins and higher administrative cost per dollar collected.

Medicaid rates run roughly 30% below Medicare. Viable as a volume play in high-enrollment markets, but not as a primary payer unless your state has competitive rates.

Commercial insurance pays 10-20% above Medicare when you negotiate well. The catch: commercial wound care volume is lower since most chronic wound patients are over 65.

The 70/20/10 Target Mix

A healthy payer mix for a wound care practice in most markets looks roughly like:

70% Medicare (FFS + Advantage combined)
20% Medicare Advantage (tracked separately from FFS for margin analysis)
10% Commercial + Medicaid + Other

If your Medicare Advantage percentage creeps above 40% of total volume, watch your per-visit margins carefully. The prior authorization overhead and lower reimbursement rates can erode profitability even at healthy visit volumes.

Cost Structure: Where the Money Goes

Here's how a typical mobile wound care practice's costs break down as a percentage of revenue:

Provider compensation: 50-60% — your largest cost line. Per-visit compensation models typically run 50-55%; salaried models run 55-60% with benefits.
Medical supplies: 10-20% — basic supplies run 8-12%. Practices with significant graft volume push to 15-20% due to skin substitute acquisition costs.
Transportation and mileage: 5-8% — vehicle costs, mileage reimbursement, fuel. Spread-out geographies push toward the higher end.
Administrative overhead: 15-20% — billing, credentialing, compliance, insurance, office expenses. In-house billing runs 15-18%; outsourced billing charges 6-10% of collections.
Technology and software: 2-5% — EHR, billing, scheduling, compliance tools. Small percentage, disproportionate impact on collection rates.

The Unit Economics Table

Here's how the math works across visit types:

Visit Type	Revenue	Supply Cost	Net Margin	Monthly Visits to Break Even*
E/M Only (99214)	$130	$5-10	~$35-45	220+
E/M + Selective Debridement	$155	$10-20	~$50-65	150-180
E/M + Excisional Debridement	$180	$15-25	~$60-75	120-150
E/M + Skin Substitute	$900	$300-600	~$100-250	40-80
E/M + NPWT	$170	$15-25	~$55-65	140-170

*Break-even assumes a solo provider with ~$8,000/month in fixed costs (own compensation, mileage, admin, technology). Net margin is after variable supply cost but before fixed costs.

The table makes the strategic point clearly: practices that do only E/M visits need heroic volume to break even. Practices with a balanced mix of E/M, debridement, and selective graft application reach profitability at achievable volumes.

Year 1 Financial Timeline

Wound care practices don't generate revenue on day one. Here's a realistic month-by-month trajectory:

Months 1-2: Credentialing window. Zero patient revenue. You're completing Medicare enrollment, payer credentialing, and operational setup. Budget for $10,000-20,000 in startup costs during this period — entity formation, insurance, initial supplies, technology setup. If you haven't started credentialing before your target launch date, add two months to every timeline below.

Months 3-4: Ramp-up. First patients, 20-40 visits per month. Revenue of $2,500-6,000/month. Below break-even. You're building referral relationships, learning your documentation workflow, and submitting your first claims. Expect your first denial and use it to calibrate your documentation process.

Months 5-6: Approaching break-even. 60-80 visits per month as referral sources start sending consistent volume. Revenue of $7,500-12,000/month. Most solo practices approach cash-flow break-even in this window if their collection rates are above 90%.

Months 7-12: Profitable operation. 80-120 visits per month. Revenue of $10,000-18,000/month depending on service mix. At this point you're generating positive cash flow and can start evaluating whether to reinvest in a second clinician. The trigger for hiring isn't "I'm busy" — it's "I'm declining referrals."

If you need capital to bridge the credentialing gap, plan for 3-4 months of operating expenses with no revenue.

What Separates Profitable from Struggling Practices

The revenue model above is achievable. But not every practice achieves it. Five operational decisions separate the practices that reach profitability from the ones that plateau or fail:

1. Collection rate discipline. The difference between collecting 88% and 95% of billed charges is $840/month at 80 visits and $150 average — over $10,000/year. Clean documentation at point of care, LCD compliance checks before submission, and aggressive denial follow-up are operational habits, not billing department problems.

2. Service mix management. Practices that default to E/M-only visits because they're "easier" leave money on the table. If a wound is clinically indicated for debridement, do it. If it meets skin substitute criteria, don't skip the application because the PA is a hassle.

3. Referral pipeline consistency. Revenue volatility almost always traces back to referral inconsistency. Practices depending on one or two referral sources are one relationship change away from a revenue crater. A diversified referral network across SNFs, home health agencies, and primary care creates stable volume.

4. Denial rate management. Every denied claim is delayed revenue at best and lost revenue at worst. Target below 5% overall and below 1% for high-value graft claims.

5. Operational visibility. Practices that track revenue per visit, denial rate by payer, days in AR, and referral conversion rate weekly spot problems before they compound. Practices that check their bank account monthly are flying blind.

This is where technology matters. A wound care platform with built-in revenue analytics — real-time per-visit revenue, payer mix trending, denial patterns — turns financial management from a monthly accounting exercise into a daily operational practice. Medipyxis provides this visibility within the clinical workflow, so you're not reconciling spreadsheets after the fact.

The Bottom Line

A solo mobile wound care provider doing 80-100 visits per month with a balanced service mix can realistically generate $10,000-15,000/month in revenue, with net margins of 25-35% after all costs. A two-provider practice at 200+ monthly visits pushes into $30,000-40,000/month territory.

These numbers are achievable, but they require operational discipline: clean documentation, aggressive collection, diversified referrals, and tight cost management. The revenue model works. The question is whether the operational model supports it.

If you're in the planning stage, start with the mobile wound care startup guide and the pricing strategy breakdown. Get the foundation right, and the revenue follows.